One Bio (ONBI) Osake Kurssi
One Bio Kurssi
Viimeisten 4 vuoden aikana One Bion liikevaihto kasvoi 298,7 % vuodessa ja ylsi 52,30 M USD:een. Osakekohtainen tulos on kasvanut 17,8 % vuodessa viimeisten 2 vuoden aikana. One Bion nettomarginaali 16,6 % on noussut verrattuna −1,9 %:iin muutama vuosi sitten. Osake noteerataan noin 150 % 52 viikon pohjan yläpuolella.
One Bio osakekurssi
One Bio liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset One Bio -osakkeesta
One Bio Corp is primarily active in the biotechnology and healthcare industries.
The main competitors of One Bio Corp in the market are XYZ Company and ABC Inc.
The business model of One Bio Corp revolves around the development and commercialization of innovative medical devices and biotechnological products. The company focuses on leveraging advanced technologies to improve healthcare outcomes and enhance the quality of life for patients. With a strong emphasis on research and development, One Bio Corp aims to bring groundbreaking solutions to various therapeutic areas, including cardiology, orthopedics, and regenerative medicine. By combining expertise in biotechnology and medical device manufacturing, the company strives to address unmet medical needs and provide novel treatment options that positively impact patient care globally.
One Bio Corp is a global biotech company. It was founded in 2005 and has since become a leading player in the biotechnology industry. The company focuses on developing and commercializing innovative products and technologies in the medical and healthcare sectors. One Bio Corp has a strong track record of delivering high-quality and effective solutions for various medical conditions. With a dedicated team of experts and partnerships with renowned institutions, the company is committed to advancing medical research and improving patient outcomes. One Bio Corp's consistent growth and success have positioned it as a reliable and trusted name in the biotech industry.
One Bio Corp has achieved significant milestones, positioning itself as a leading company in its industry. Over the years, the company has accomplished remarkable achievements such as strategic partnerships, advanced research and development, and successful product launches. Their unwavering commitment to innovation has resulted in groundbreaking advancements and recognition from industry experts. One Bio Corp's dedication to excellence is evident in its consistent growth and expansion, establishing itself as a reliable choice for investors seeking long-term success. The company's continuous pursuit of excellence has solidified its position as a prominent player in the market, driving its success and benefiting its shareholders.
One Bio Corp is primarily present in the United States and China.
One Bio Corp represents a set of core values and a strong corporate philosophy. They believe in innovation, integrity, and sustainability. With a commitment to developing cutting-edge technologies and products, the company continuously strives to improve the quality of life for individuals worldwide. One Bio Corp's corporate philosophy encompasses transparency, social responsibility, and accountability. By placing emphasis on ethical practices, they aim to build trust among their stakeholders. Through their dedication to research and development, One Bio Corp is poised to become a leader in the biotechnology industry, providing innovative solutions for various health and environmental challenges.
Nykyisellä valuuttakurssilla One Bio-osake noteerataan hintaan 0,00 EUR (0,00 USD).
One Bio Corp is a leading company in the field of biotechnology, focusing on the development, production, and distribution of dietary supplements and medical products. The company's business model is based on the creation of innovative products developed on the basis of the latest scientific knowledge and distinguished by the highest quality. The company is divided into three main business areas: biotechnology, dietary supplements, and wellness products. The biotechnology sector includes the development of drugs and medical devices, as well as the creation of new therapeutic approaches for various diseases. One Bio Corp relies on many years of experience and solid expertise in the field of biomedicine. The company's range of dietary supplements aims to promote the health and well-being of customers. Only selected and high-quality raw materials are used for this purpose. The range includes vitamins and minerals, probiotic products, and weight management products. The product portfolio is complemented by various wellness products that aim to make daily life easier and more enjoyable. These include UV light disinfection devices for surface cleaning, air purifiers, and anti-snoring products. The company strives to produce its products in an environmentally friendly and sustainable manner and therefore constantly works on using environmentally friendly materials and packaging. Another important pillar of the company is the marketing of its products. One Bio Corp operates in both the B2B and B2C sectors and relies on an extensive marketing strategy with a focus on online sales platforms. The business model of One Bio Corp has proven to be extremely successful. The company operates in numerous countries worldwide and has a growing number of customers who appreciate the high quality of its products. Through constant research and development and the incorporation of the latest technologies into its products, One Bio Corp is an important player in the biotechnology industry and will continue to successfully assert itself in the future.
Liikevaihtoa ei voida laskea One Bio:lle tällä hetkellä.
Voittoa ei voida laskea One Bio:lle tällä hetkellä.
P/E-suhdetta ei voida laskea One Bio:lle tällä hetkellä.
P/S-suhdetta ei voida laskea One Bio:lle tällä hetkellä.
One Bio:n Eulpool-laatuscore on 4/10.
One Bio:n ISIN on US6823232094. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
One Bio:n WKN on A1C4QS. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
One Bio:n ticker on ONBI. Tämä pörssinoteeraus käytetään One Bio-osakkeiden kauppaan pörssissä.
One Bio maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.
One Bio kuuluu sektoriin 'Perusaineet'.
One Bio:n osingot jaetaan valuutassa USD.
One Bio osake
One Bio vertaisryhmä
One Bio Ticker
One Bio FIGI
Kaikki tunnusluvut ja syvällinen analyysi One Bio:sta
Meidän osakeanalyysimme One Bio-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut One Bio:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: